Optimal Effect-site Concentration of Remifentanil for Inhibiting Response to Laryngeal Mask Airway (LMA) Removal

Clinical trial NCT01915108 · COMPLETED

Trial details

NCT number: NCT01915108
Sponsor: Sangjin Park
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Respiratory Complication

Start date: 2012-07-01
Primary completion: 2013-06-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.